focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.40
Bid: 326.40
Ask: 326.60
Change: 0.00 (0.00%)
Spread: 0.20 (0.061%)
Open: 327.70
High: 328.20
Low: 325.20
Prev. Close: 326.40
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Cash Tender Offer

4 Apr 2023 14:11

RNS Number : 3612V
NatWest Group plc
04 April 2023
 

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL (SEE "OFFER RESTRICTIONS" BELOW).

 

THIS ANNOUNCEMENT IS FOR INFORMATION ONLY AND IS NOT AN OFFER TO PURCHASE OR A SOLICITATION OF AN OFFER TO SELL ANY SECURITIES.

 

,

 

 

April 4, 2023

 

NATWEST GROUP PLC - RESULTS OF THE CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 5.125% SUBORDINATED TIER 2 NOTES DUE 2024

NatWest Group plc (the "Offeror") is announcing today the results of its previously announced cash tender offer (the "Offer") for any and all of its outstanding 5.125% Subordinated Tier 2 Notes due 2024 (the "Notes").

The Offer was made on the terms and subject to the conditions set out in the offer to purchase dated March 27, 2023 and the related Notice of Guaranteed Delivery (the "Offer to Purchase"). Capitalized terms not otherwise defined in this announcement have the same meaning as in the Offer to Purchase.

Results of the Offer

The Tender Agent informed the Offeror that $339,732,000 in aggregate principal amount of the Notes were validly tendered and not validly withdrawn by 5:00 p.m., New York City time, on April 3, 2023 (the "Expiration Deadline"), as more fully set forth in the table below. The Offeror has accepted all Notes that were validly tendered and not validly withdrawn prior to the Expiration Deadline. As of the Expiration Deadline, no Notes were tendered using the Guaranteed Delivery Procedures.

The Offeror estimates that the impact on its Q2 2023 results will be de minimis.

With respect to the Offer, the table below sets forth, among other things, the principal amount of Notes validly tendered and not validly withdrawn at or prior to the Expiration Deadline:

Title of Security

Issuer(1)

ISIN/CUSIP

Principal Amount Outstanding

Aggregate Principal Amount Tendered Excluding Notes Tendered Using Guaranteed Delivery Procedures

Purchase Price(2)

5.125% Subordinated Tier 2 Notes due 2024

The Royal Bank of Scotland Group plc(1)

US780099CH81 /

780099CH8

$876,108,000

$339,732,000

$996.76

 

(1) Now NatWest Group plc.

(2) Per $1,000 principal amount of the Notes validly tendered and accepted for purchase.

 

The Settlement Date is expected to be April 5, 2023 and the Guaranteed Delivery Settlement Date is expected to be April 6, 2023. For the avoidance of doubt, Holders whose Notes are tendered and purchased pursuant to the Guaranteed Delivery Procedures will not receive payment in respect of any interest or any distribution, as the case may be, for the period from and including the Settlement Date to the Guaranteed Delivery Settlement Date.

 

FURTHER INFORMATION

 

Kroll Issuer Services Limited acted as tender agent with respect to the Offer. NatWest Markets Securities Inc., an affiliate of the Offeror, acted as Global Arranger and Lead Dealer Manager with respect to the Offer. TD Securities (USA) LLC (together with NatWest Markets Securities Inc.) acted as Dealer Manager with respect to the Offer.

 

Questions regarding the Offer should be directed to NatWest Markets Securities Inc. at +44 20 7678 5222 (UK), +1 203 897 6166 (U.S.) or +1 866 884 2071 (U.S. Toll Free) and TD Securities (USA) LLC at +1 212 827 2842 (U.S.) or +1 866 584 2096 (U.S. Toll Free).

 

FORWARD-LOOKING STATEMENTS

 

From time to time, the Offeror may make statements, both written and oral, regarding its assumptions, projections, expectations, intentions or beliefs about future events. These statements constitute "forward-looking statements". The Offeror cautions that these statements may and often do vary materially from actual results. Accordingly, the Offeror cannot assure you that actual results will not differ materially from those expressed or implied by the forward-looking statements. You should read the sections entitled "Risk Factors" in the Offer to Purchase and in the Annual Report of the Offeror on Form 20-F, which is incorporated by reference therein, and in the section entitled "Forward-Looking Statements" in the Annual Report of the Offeror on Form 20-F, which is incorporated by reference in the Offer to Purchase.

 

Any forward-looking statements made herein, the Offer to Purchase or in the documents incorporated by reference therein speak only as of the date they are made. Except as required by the U.K. Financial Conduct Authority, any applicable stock exchange or any applicable law, the Offeror expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained herein, in the Offer to Purchase or the documents incorporated by reference therein to reflect any changes in expectations with regard thereto or any new information or any changes in events, conditions or circumstances on which any such statement is based. The reader should, however, consult any additional disclosures that the Offeror has made or may make in documents that the Offeror has filed or may file with the U.S. Securities and Exchange Commission.

 

 

Legal Entity Identifier

NatWest Group plc

2138005O9XJIJN4JPN90

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEXZLFBXZLFBBB
Date   Source Headline
17th Jan 202310:16 amRNSTR1 - Notification of Major Holdings
30th Dec 202211:38 amRNSTotal Voting Rights and Capital
21st Dec 202210:04 amRNSTR-1: Notification of Major Holdings
16th Dec 20229:33 amRNSDirectorate Change
7th Dec 20225:36 pmRNSPublication of a Prospectus
2nd Dec 20224:37 pmRNSPublication of Final Terms
30th Nov 20223:02 pmRNSTotal Voting Rights
25th Nov 20222:00 pmRNSDirector/PDMR Shareholding
24th Nov 202211:00 amRNSDirector Declaration
23rd Nov 20224:08 pmRNSDividend Declaration
11th Nov 20227:00 amRNSQ3 2022 Pillar 3 Supplements
10th Nov 20223:53 pmRNSDirector/PDMR Shareholding
8th Nov 20224:55 pmRNSHolding(s) in Company
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
4th Nov 202211:19 amRNSPricing of USD 7.472% Senior Callable Notes
31st Oct 20223:35 pmRNSTotal Voting Rights
28th Oct 20225:52 pmRNSPublication of Suppl.Prospcts
28th Oct 20227:00 amRNSNWG Q3 IMS Interim Management Statement 2022
20th Oct 20229:00 amRNSNatWest and Vodeno Create Strategic Partnership
5th Oct 20221:51 pmRNSBlock listing six monthly return
30th Sep 20222:15 pmRNSDirectorate Change
30th Sep 202212:45 pmRNSTotal Voting Rights
26th Sep 20225:44 pmRNSPublication of Suppl.Prospcts
26th Sep 20223:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20225:25 pmRNSChanges to our Board
23rd Sep 202212:30 pmRNSNatWest Group notes rating actions by Moody's
20th Sep 20229:30 amRNSTR-1: Notification of Major Holdings
20th Sep 20228:00 amRNSBank of America Annual Financials CEO Conference
13th Sep 20228:30 amRNSBarclays Global Financial Services Conference
8th Sep 20222:00 pmRNSDirector/PDMR Shareholding
5th Sep 202211:18 amRNSAdam & Company Private Banking Business
2nd Sep 20222:43 pmRNSPublication of Final Terms - Replacement
2nd Sep 20221:44 pmRNSPublication of Final Terms
31st Aug 20226:23 pmRNSAdjustment to conversion prices for NWG's AT1s
31st Aug 20222:34 pmRNSTotal Voting Rights
30th Aug 20228:10 amRNSShare consolidation and total voting rights
25th Aug 20224:32 pmRNSResult of General Meeting and Class Meeting
25th Aug 20222:00 pmRNSGeneral Meeting and Class Meeting Statement
12th Aug 20222:23 pmRNSUpdate to Financial Impact of Tender Offers
12th Aug 20227:00 amRNSH1 2022 Pillar 3 Supplements
11th Aug 202210:15 amRNSHolding(s) in Company
10th Aug 20226:18 pmRNSFinancial Impact of Tender Offers
10th Aug 20224:30 pmRNSDirector/PDMR Shareholding
9th Aug 20226:26 pmRNSResults of Tender Offers
9th Aug 202211:08 amRNSPricing of Tender Offers
9th Aug 20227:00 amRNSNotice of General Meeting and Class Meeting
1st Aug 20225:02 pmRNSTender Offer
1st Aug 20224:32 pmRNSPublication of Final Terms
29th Jul 20224:59 pmRNSPublication of Supplementary Prospectus
29th Jul 20223:19 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.